Iron in chronic brain disorders: imaging and neurotherapeutic implications
- PMID: 17599703
- PMCID: PMC1963417
- DOI: 10.1016/j.nurt.2007.05.006
Iron in chronic brain disorders: imaging and neurotherapeutic implications
Abstract
Iron is important for brain oxygen transport, electron transfer, neurotransmitter synthesis, and myelin production. Though iron deposition has been observed in the brain with normal aging, increased iron has also been shown in many chronic neurological disorders including Alzheimer's disease, Parkinson's disease, and multiple sclerosis. In vitro studies have demonstrated that excessive iron can lead to free radical production, which can promote neurotoxicity. However, the link between observed iron deposition and pathological processes underlying various diseases of the brain is not well understood. It is not known whether excessive in vivo iron directly contributes to tissue damage or is solely an epiphenomenon. In this article, we focus on the imaging of brain iron and the underlying physiology and metabolism relating to iron deposition. We conclude with a discussion of the potential implications of iron-related toxicity to neurotherapeutic development.
References
-
- Gutteridge JM. Iron and oxygen radicals in brain. Ann Neurol. 1992;32:S16–S21. - PubMed
-
- Pujol J, Juque C, Vendrell P, et al. Biological significance of iron-related magnetic resonance imaging changes in the brain. Arch Neurol. 1992;49:711–717. - PubMed
-
- Riederer P, Sofic E, Rausch WD, et al. Transition metals, ferritin, glutathione, and ascorbic acid in parkinsonian brains. J Neurochem. 1989;52:515–520. - PubMed
-
- Dexter DT, Wells FR, Agid F, et al. Increased nigral iron content in post-mortem parkinsonian brain. Lancet. 1987;341:1219–1220. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
